Clinical Trials Logo

Clinical Trial Summary

It is aimed in this study to examine the changes in brain blood supply and oxygenation in neonatal premature babies who have anemia and who underwent erythrocyte suspension transfusion in the light of original guidelines by means of obtaining measurements with the help of cranial doppler ultrasonography and near-infrared spectroscopy.


Clinical Trial Description

Anemia in newborn babies is defined as the mean of hemoglobin values according to postnatal age is below 2 standard deviations. Disruption in tissue perfusion and oxygenation, hyperdynamic cardiac failure, increase in need of oxygen, increase in respiratory effort, inability to be separated from mechanical ventilation, failure to thrive, paleness, increase in frequency of morbidities of prematurity (necrotizing enterocolitis, retinopathy of prematurity, intraventricular hemorrhage, etc.) may be seen as a result of progressive anemia. When critical hemoglobin values are reached in premature newborn babies with concomitant disruption of tissue oxygenation, transfusion is performed with erythrocyte suspensions. The main goal here is to correct impaired tissue oxygenation, provide perfusion in sufficient quantity, and prevent anemia-related morbidities. Although frequently applied, there is no consensus in our country and in the world regarding threshold hemoglobin values and supporting parameters for transfusions. As a result, there are no guidelines prepared for newborns based on evidence with clearly defined borders and accepted by everyone. Many countries and centers implement different transfusion protocols based on their experience. Given the risk of oxygen radical damage and associated diseases as a result of erythrocyte transfusions (infections, bone marrow suppression, necrotizing enterocolitis, retinopathy of prematurity, etc.), there is a need to develop new methods for taking and supporting transfusion decision, and to prepare more objective and more accepted guidelines. The origin of our study is the subsequent protective compensation mechanisms after deterioration in brain oxygenation due to symptomatic anemia in premature newborn babies. For these reasons, it is aimed to examine the changes in brain blood supply and oxygenation in neonatal premature babies who have anemia and who underwent erythrocyte suspension transfusion in the light of original guidelines by means of obtaining measurements with the help of cranial doppler ultrasonography and near-infrared spectroscopy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04509375
Study type Observational
Source Hacettepe University
Contact Hasan Tolga Çelik
Phone +90 530 592 55 84
Email htcelik@gmail.com
Status Recruiting
Phase
Start date March 14, 2019
Completion date June 23, 2021

See also
  Status Clinical Trial Phase
Completed NCT00167388 - The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants Phase 1
Completed NCT01735578 - Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis N/A
Recruiting NCT04497012 - Iron Supplementation and Intestinal Health Phase 4
Completed NCT01539356 - Hepcidin Levels in Preterm Infants N/A
Completed NCT02101086 - Autologous Cord Blood Transfusion in Preterm Infants N/A
Terminated NCT01735552 - Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates N/A
Completed NCT00458068 - Early Versus Late Enteral Iron in Infants Less Than 1301 Grams N/A
Not yet recruiting NCT06220461 - Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants N/A
Withdrawn NCT01121328 - Autologous Umbilical Cord Blood Transfusion for Preterm Neonates Phase 1
Completed NCT01393496 - Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants Phase 4
Completed NCT00182390 - Premature Infants in Need of Transfusion (PINT) Phase 3
Completed NCT00457990 - Neurodevelopment After Early Iron Supplementation N/A